REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
09 September 2014
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business
Corporate News tagged:
Stem Cells (3)
09 September 2014
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business